Wound infections		Possible therapeutic alternatives
Wound: Infected, post-op or trauma, without sepsis. (Not Gastrointestinal tract or female genital tract.)	Common pathogens	Cephalexin 500mg orally 4 times daily or  Duricef 1 gram orally once daily or cin 500mg po q12h or Augmentin 500mg orally three times daily   or  Dicloxacillin 500mg orally 4 times daily +/- Ciprofloxacin
Wound infection + sepsis. (does not include surgery involving GI or female genital tract)	Common pathogens	Ampicillin-sulbactam 1.5 - 3 grams IV every 6 hours  or Ticarcillin-clavulanic acid  3.1 grams  IV every 6 hours or   Piperacillin-tazobactam 3.375 grams IV every 6 hours or  Cefazolin 1 gram  IV every 8 hours.
Postop wound (surgery involving gastrointestinal tract or female genital tract)  (all regimens must cover anaerobes)	Common pathogens	Cefotetan 2 grams ivpb q12h or   or  Cefoxitin 1 gram IV every 6 hours or Ticarcillin-clavulanic acid  3.1grams IV every 6 hours  or  Ampicillin-sulbactam 1.5-3g ivpb q6h or   [ (Cefotaxime 1g ivpb q8h or Ceftriaxone1-2g ivpb q24h ) +  Metronidazole 500mg ivpb q6-8h]  or Imipenem 500mg ivpb q6h.

References

American Hospital Formulary Service.  Drug Information. Bethesda, MD: ASHP, 1997.

Baden LR, Eisenstein BI.Impact of Antibiotic Resistance on the Treatment of Gram-negative Sepsis. Curr Infect Dis Rep. 2000 Oct;2(5):409-416.

Bartlett JG et al. Community-acquired pneumonia in adults: guidelines for management. Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 1998;26:811-38.

Bartlett JG: Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices. Semin Respir Infect 1997 Dec; 12(4): 329-33

Bartlett JG.1998 Pocket Book of Infectious Disease Therapy., Ninth Edition. Baltimore,MD: Williams&Wikins,1998.

Bernstein JM: Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America. Chest 1999 Mar; 115(3 Suppl): 9S-13S

Drug Information Handbook, 5th Ed. 1997, Lexi-Comp inc.

Ewig S et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. Am J Respir Crit Care Med. 1999;159:1835-42.

File TM Jr. Community-acquired pneumonia: recent guidelines for therapy. J Respir Dis. 1999;20:534-41.

Gilbert DN, Moellering RC, Sande MA. The Sanford Guide to Antimicrobial Therapy 2000. 30th ed. Hyde Park,VT: Antimicrobial Therapy, Inc.; 2000.

Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med. 1996;335:1445-1453.

Gonzales R, Sande M: What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet 1995 Mar 18; 345(8951): 665-6

Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-581.

Lipsky BA, Berendt AR.Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S42-6.

Mufson MA.Pneumococcal Pneumonia. Curr Infect Dis Rep. 1999 Apr;1(1):57-64.

Reese RE, Betts RF: A Practical Approach to Infectious Diseases. 4th ed. Boston: Little, Brown, and Company; 1996: 251

Stefani SD, Cadore LP, Villaroel RU, Azevedo S, Machado AL. Antibiotic Selection in the Treatment of Febrile Neutropenia: Current Approach and New Directions. Braz J Infect Dis. 1998 Jun;2(3):109-117.

Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-1334.